Tizona Therapeutics
About:
Tizona develops next-generation immunotherapies
Website: http://tizonatx.com/
Top Investors: Canaan Partners, Astellas Venture Management, Gilead Sciences, Amgen Ventures, Abingworth
Description:
The company is establishing collaborations with its scientific founders “to better understand whether regulatory T cells play a more prominent role in certain tumors,” he added. Although research suggests that Tregs cells play a more prominent role in creating immunosuppression in the microenvironment in some tumor types than others, “quite honestly, the data are lacking. One of the ways we’re going to differentiate the company is to understand that relationship better.
$370M
$1M to $10M
South San Francisco, California, United States
2014-01-01
info(AT)tizonatx.com
Emerging Unicorn
Charles Drake, Dario Vignali, Drew Pardoll, Jedd Wolchok, Vijay Kuchroo
11-50
2020-07-21
Private
© 2025 bioDAO.ai